C78.01

Secondary malignant neoplasm of right lung

Secondary malignant neoplasm of the right lung, commonly referred to as pulmonary metastasis, occurs when cancer cells from a primary tumor located elsewhere in the body spread to the right lung tissue. The lungs are the second most common site for metastatic disease because they receive the entire venous output of the heart through the pulmonary arteries, acting as a filter for circulating tumor cells. In the case of code C78.01, the clinical evidence confirms that metastatic lesions have seeded specifically within the parenchyma of the right lung. These metastases often appear as multiple, discrete 'cannonball' lesions on radiographic imaging, though solitary pulmonary nodules are also possible. Primary cancers that most frequently metastasize to the lung include those originating in the breast, colon, kidney (renal cell carcinoma), head and neck, and musculoskeletal system (sarcomas). Treatment typically focuses on the primary malignancy, although localized therapies like metastasectomy or stereotactic body radiation therapy (SBRT) may be indicated in oligometastatic cases.

Clinical Symptoms

Chronic, persistent cough
Dyspnea (shortness of breath) upon exertion or at rest
Hemoptysis (coughing up blood or blood-streaked sputum)
Pleuritic chest pain in the right thoracic region
Unexplained weight loss and cachexia
Fatigue and generalized malaise
Wheezing localized to the right side
Pleural effusion (accumulation of fluid in the pleural space)
Dullness to percussion in the right lung base
Superior vena cava syndrome (in cases of hilar lymph node involvement)

Common Causes

Hematogenous spread of primary adenocarcinoma (e.g., breast, colon, or prostate)
Lymphatic spread from extrathoracic primary sites
Metastatic renal cell carcinoma
Malignant melanoma
Osteosarcoma or soft tissue sarcomas
Direct extension from adjacent mediastinal or diaphragmatic structures
Advanced stage of primary gastrointestinal malignancies

Documentation & Coding Tips

Explicitly identify the primary malignancy site and its current status.

Example: Patient with established metastatic clear cell renal cell carcinoma (C64.1) of the right kidney, status post radical nephrectomy. Current surveillance CT chest reveals a new 2.4 cm enlarging mass in the right lower lobe consistent with secondary malignant neoplasm of the right lung (C78.01). The primary site is currently considered active metastatic disease requiring initiation of systemic immunotherapy.

Billing Focus: Documentation must link the secondary lung neoplasm (C78.01) to the primary site (C64.1) to support medical necessity for systemic treatments and establish the sequence of malignancy codes.

Specify laterality for all pulmonary metastatic lesions to ensure code precision.

Example: Follow-up for metastatic colon adenocarcinoma. Imaging confirms a solitary 1.5 cm nodule in the right middle lobe, representing a secondary malignant neoplasm of the right lung (C78.01). No lesions noted in the left lung. Plan for stereotactic body radiation therapy (SBRT) to the right-sided lesion.

Billing Focus: Laterality is a required component of the C78 series. Using C78.01 (Right) instead of C78.00 (Unspecified) prevents claim denials and ensures compliance with 2026 specificity standards.

Distinguish between a primary lung cancer and a secondary metastasis from a distant site.

Example: Biopsy of the right upper lobe mass confirms metastatic breast carcinoma (ER+/PR-), not primary bronchogenic carcinoma. Diagnosed as secondary malignant neoplasm of the right lung (C78.01). Patient has a history of right-sided stage IIIA invasive ductal carcinoma (Z85.3). This distinction is critical as it changes the staging from localized lung disease to Stage IV systemic disease.

Billing Focus: Prevents incorrect use of C34 codes (Primary Lung Cancer). Coding C78.01 instead of C34.11 significantly alters the treatment pathway and medical necessity for specific oncology drugs.

Document associated complications such as malignant pleural effusion or lymphadenopathy.

Example: Secondary malignant neoplasm of the right lung (C78.01) complicated by an associated malignant pleural effusion (J91.0) and right-sided hilar lymphadenopathy (C77.1). Patient requires therapeutic thoracentesis for symptomatic relief of dyspnea.

Billing Focus: Including J91.0 (Malignant Pleural Effusion) as a secondary diagnosis justifies the use of CPT 32554 or 32555 and increases the encounter's complexity level.

Differentiate between current active primary cancer and personal history of primary cancer.

Example: Assessment: Secondary malignant neoplasm of the right lung (C78.01). Primary site was malignant neoplasm of the sigmoid colon (C18.7), which was surgically resected three years ago and is no longer under active treatment, now documented as personal history of malignant neoplasm of the colon (Z85.038). Current metastatic pulmonary disease is the focus of care.

Billing Focus: Properly sequencing C78.01 as the principal diagnosis (if it is the reason for encounter) and Z85.038 as a secondary code ensures the bill reflects that the primary site is no longer active.

Relevant CPT Codes

99214 - Office or other outpatient visit, established patient, 30-39 minutes
Typically used for follow-up oncology visits where metastatic progression or treatment side effects are managed with moderate complexity.
99215 - Office or other outpatient visit, established patient, 40-54 minutes
Required when the patient has severe complications, treatment failure, or requires complex discussion regarding end-of-life care or aggressive new therapy lines.
32666 - Thoracoscopy, surgical; with therapeutic wedge resection
This is a common procedure used to surgically remove a solitary secondary neoplasm from the right lung for both diagnosis and treatment.
31622 - Bronchoscopy, diagnostic, with cell washing
Used to evaluate the airways and obtain samples from a lung mass to confirm the secondary nature of the malignancy.
71260 - CT Chest with contrast material
The standard imaging modality for identifying and monitoring the size and number of metastatic nodules in the right lung.
78815 - PET/CT, skull base to mid-thigh
Used to determine the metabolic activity of the right lung lesion and to search for other metastatic sites throughout the body.
32555 - Thoracentesis, puncture of pleural cavity for aspiration, with imaging guidance
Often required when a secondary lung neoplasm causes a malignant pleural effusion requiring drainage for symptom relief.
96413 - Chemotherapy administration, intravenous infusion; up to 1 hour
Used for the administration of systemic agents targeted at treating the secondary malignant neoplasm.
32701 - Thoracic stereotactic body radiation therapy (SBRT)
A non-invasive treatment option for a solitary metastasis in the right lung, particularly for patients who are not surgical candidates.
32440 - Pneumonectomy, total
Rarely performed for secondary neoplasms, but may be necessary if the metastatic burden is extensive but localized to one lung.